TY  - JOUR
AU  - Picornell, A C
AU  - Echavarria, I
AU  - Alvarez, E
AU  - López-Tarruella, S
AU  - Jerez, Y
AU  - Hoadley, K
AU  - Parker, J S
AU  - Del Monte-Millán, M
AU  - Ramos-Medina, R
AU  - Gayarre, J
AU  - Ocaña, I
AU  - Cebollero, M
AU  - Massarrah, T
AU  - Moreno, F
AU  - García Saenz, J A
AU  - Gómez Moreno, H
AU  - Ballesteros, A
AU  - Ruiz Borrego, M
AU  - Perou, C M
AU  - Martin, M
PY  - 2019
DO  - 10.1186/s12864-019-5849-0
UR  - http://hdl.handle.net/10668/14068
T2  - BMC genomics
AB  - Full RNA-Seq is a fundamental research tool for whole transcriptome analysis. However, it is too costly and time consuming to be used in routine clinical practice. We evaluated the transcript quantification agreement between RNA-Seq and a digital...
LA  - en
KW  - Breast cancer
KW  - Multiplexed gene expression
KW  - PAM50
KW  - RNA-Seq
KW  - Triple negative breast cancer
KW  - Biomarkers, Tumor
KW  - Female
KW  - Follow-Up Studies
KW  - Gene Expression Profiling
KW  - Gene Expression Regulation, Neoplastic
KW  - High-Throughput Nucleotide Sequencing
KW  - Humans
KW  - Male
KW  - Neoplasm Recurrence, Local
KW  - Prognosis
KW  - Prospective Studies
KW  - Triple Negative Breast Neoplasms
TI  - Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series.
TY  - research article
VL  - 20
ER  -